Compass Pathways Plc buy BiotechBee
Start price
08.06.25
/
60%
€4.26
Target price
31.08.27
€8.00
Performance (%)
-43.66%
End price
29.06.25
€2.40
Summary
This prediction ended on 29.06.25 with a price of €2.40. Massive losses of -43.66% were the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Compass Pathways Plc | - | - | - |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
According to BiotechBee what are the pros and cons of Compass Pathways Plc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year